Concepts (208)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Toll-Like Receptors | 11 | 2024 | 92 | 4.590 |
Why?
|
| Adjuvants, Immunologic | 14 | 2023 | 167 | 4.240 |
Why?
|
| Polymers | 11 | 2021 | 202 | 2.990 |
Why?
|
| NF-kappa B | 6 | 2024 | 445 | 2.460 |
Why?
|
| Immunity, Innate | 7 | 2024 | 409 | 2.330 |
Why?
|
| Vaccines | 5 | 2023 | 80 | 1.920 |
Why?
|
| Dendritic Cells | 7 | 2023 | 425 | 1.760 |
Why?
|
| Dinitrochlorobenzene | 2 | 2022 | 3 | 1.570 |
Why?
|
| Toll-Like Receptor 4 | 3 | 2024 | 88 | 1.450 |
Why?
|
| Toll-Like Receptor 2 | 2 | 2020 | 33 | 1.340 |
Why?
|
| Lipopeptides | 2 | 2021 | 16 | 1.310 |
Why?
|
| Biomimetic Materials | 2 | 2021 | 22 | 1.250 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 2021 | 126 | 1.250 |
Why?
|
| Light | 3 | 2017 | 289 | 1.140 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 2 | 2023 | 22 | 1.120 |
Why?
|
| Inflammasomes | 2 | 2023 | 23 | 1.110 |
Why?
|
| Antigen Presentation | 3 | 2022 | 209 | 1.050 |
Why?
|
| Nanoparticles | 3 | 2023 | 157 | 1.010 |
Why?
|
| CD8-Positive T-Lymphocytes | 3 | 2023 | 559 | 0.950 |
Why?
|
| Macrophages | 4 | 2024 | 557 | 0.910 |
Why?
|
| Dermatitis, Contact | 1 | 2022 | 6 | 0.870 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2022 | 57 | 0.840 |
Why?
|
| Allergens | 2 | 2022 | 179 | 0.840 |
Why?
|
| Cancer Vaccines | 1 | 2023 | 156 | 0.810 |
Why?
|
| Disulfides | 1 | 2021 | 64 | 0.790 |
Why?
|
| Mechanical Phenomena | 1 | 2021 | 13 | 0.790 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2021 | 26 | 0.790 |
Why?
|
| Ovalbumin | 1 | 2021 | 109 | 0.770 |
Why?
|
| Mutant Proteins | 1 | 2021 | 94 | 0.770 |
Why?
|
| Lignans | 1 | 2020 | 6 | 0.770 |
Why?
|
| Vibration | 1 | 2021 | 49 | 0.770 |
Why?
|
| Biphenyl Compounds | 1 | 2020 | 68 | 0.750 |
Why?
|
| Oligonucleotides | 1 | 2021 | 92 | 0.750 |
Why?
|
| Antigens | 1 | 2021 | 228 | 0.720 |
Why?
|
| Immunoassay | 1 | 2020 | 92 | 0.720 |
Why?
|
| Immunologic Factors | 2 | 2022 | 170 | 0.710 |
Why?
|
| Animals | 23 | 2023 | 26589 | 0.700 |
Why?
|
| Mice | 14 | 2023 | 11356 | 0.680 |
Why?
|
| Lactic Acid | 3 | 2014 | 90 | 0.680 |
Why?
|
| Lymphocytes | 1 | 2020 | 464 | 0.630 |
Why?
|
| Molecular Structure | 7 | 2019 | 287 | 0.630 |
Why?
|
| Toll-Like Receptor 6 | 1 | 2017 | 5 | 0.620 |
Why?
|
| Hydrogels | 2 | 2008 | 82 | 0.620 |
Why?
|
| Drug Discovery | 1 | 2018 | 103 | 0.620 |
Why?
|
| Optogenetics | 1 | 2016 | 30 | 0.580 |
Why?
|
| Receptors, Immunologic | 1 | 2016 | 135 | 0.560 |
Why?
|
| RAW 264.7 Cells | 3 | 2021 | 16 | 0.540 |
Why?
|
| Molecular Probes | 1 | 2015 | 35 | 0.520 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2014 | 5 | 0.500 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2014 | 8 | 0.500 |
Why?
|
| Lymphocyte Activation | 1 | 2017 | 728 | 0.500 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2013 | 23 | 0.480 |
Why?
|
| Microscopy, Atomic Force | 2 | 2024 | 52 | 0.480 |
Why?
|
| Teichoic Acids | 1 | 2013 | 18 | 0.470 |
Why?
|
| Models, Cardiovascular | 1 | 2013 | 98 | 0.460 |
Why?
|
| Colorimetry | 2 | 2012 | 8 | 0.450 |
Why?
|
| Polyesters | 5 | 2019 | 41 | 0.440 |
Why?
|
| Lipopolysaccharides | 1 | 2013 | 286 | 0.420 |
Why?
|
| Vaccines, Synthetic | 3 | 2022 | 55 | 0.420 |
Why?
|
| Gases | 1 | 2012 | 30 | 0.410 |
Why?
|
| Composite Resins | 1 | 2011 | 4 | 0.410 |
Why?
|
| Models, Molecular | 7 | 2018 | 1286 | 0.400 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 188 | 0.390 |
Why?
|
| Water | 2 | 2012 | 277 | 0.390 |
Why?
|
| Antifreeze Proteins | 1 | 2010 | 6 | 0.390 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2021 | 20 | 0.380 |
Why?
|
| Q Fever | 2 | 2021 | 8 | 0.380 |
Why?
|
| Coxiella burnetii | 2 | 2021 | 11 | 0.380 |
Why?
|
| Bacterial Vaccines | 2 | 2021 | 41 | 0.380 |
Why?
|
| Polymerization | 5 | 2021 | 32 | 0.370 |
Why?
|
| Inflammation | 1 | 2015 | 924 | 0.350 |
Why?
|
| Metallothionein | 1 | 2008 | 13 | 0.340 |
Why?
|
| Metals, Heavy | 1 | 2008 | 15 | 0.330 |
Why?
|
| Cross-Linking Reagents | 1 | 2008 | 86 | 0.330 |
Why?
|
| Cell Line | 4 | 2019 | 2469 | 0.330 |
Why?
|
| Proteins | 3 | 2010 | 777 | 0.330 |
Why?
|
| Neoplasms | 1 | 2023 | 2898 | 0.310 |
Why?
|
| Mice, Inbred C57BL | 4 | 2022 | 3095 | 0.300 |
Why?
|
| Materials Testing | 2 | 2021 | 91 | 0.290 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2021 | 683 | 0.290 |
Why?
|
| Vaccines, Subunit | 3 | 2021 | 55 | 0.290 |
Why?
|
| Mice, Inbred BALB C | 3 | 2022 | 1047 | 0.260 |
Why?
|
| Receptors, Pattern Recognition | 1 | 2024 | 19 | 0.240 |
Why?
|
| Pathogen-Associated Molecular Pattern Molecules | 1 | 2022 | 4 | 0.220 |
Why?
|
| Temperature | 4 | 2021 | 396 | 0.220 |
Why?
|
| Humans | 13 | 2023 | 86653 | 0.220 |
Why?
|
| Cells, Cultured | 2 | 2020 | 2819 | 0.220 |
Why?
|
| Immunity, Cellular | 1 | 2023 | 177 | 0.210 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2022 | 46 | 0.210 |
Why?
|
| Gels | 1 | 2021 | 48 | 0.200 |
Why?
|
| Vaccines, Conjugate | 1 | 2021 | 6 | 0.200 |
Why?
|
| Click Chemistry | 1 | 2021 | 4 | 0.200 |
Why?
|
| Zinc Oxide | 1 | 2021 | 3 | 0.200 |
Why?
|
| Autoantigens | 1 | 2022 | 127 | 0.200 |
Why?
|
| Cell-Free System | 1 | 2021 | 51 | 0.200 |
Why?
|
| Influenza Vaccines | 1 | 2022 | 142 | 0.200 |
Why?
|
| Heat-Shock Proteins | 1 | 2022 | 179 | 0.200 |
Why?
|
| Sulfhydryl Compounds | 1 | 2021 | 69 | 0.190 |
Why?
|
| Lipid A | 1 | 2020 | 3 | 0.190 |
Why?
|
| Polystyrenes | 1 | 2020 | 9 | 0.190 |
Why?
|
| Antigen-Presenting Cells | 1 | 2021 | 139 | 0.190 |
Why?
|
| Nanostructures | 1 | 2021 | 77 | 0.180 |
Why?
|
| Models, Animal | 1 | 2021 | 263 | 0.180 |
Why?
|
| Ligands | 1 | 2021 | 433 | 0.180 |
Why?
|
| Immune Tolerance | 1 | 2022 | 337 | 0.180 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2022 | 295 | 0.170 |
Why?
|
| Immunotoxins | 1 | 2019 | 14 | 0.170 |
Why?
|
| Carrier Proteins | 1 | 2023 | 673 | 0.170 |
Why?
|
| Influenza, Human | 1 | 2022 | 329 | 0.170 |
Why?
|
| Vaccination | 1 | 2021 | 254 | 0.170 |
Why?
|
| Transfection | 1 | 2021 | 896 | 0.170 |
Why?
|
| Oligopeptides | 1 | 2020 | 179 | 0.170 |
Why?
|
| HEK293 Cells | 1 | 2021 | 615 | 0.170 |
Why?
|
| Immune System | 2 | 2023 | 93 | 0.170 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 93 | 0.170 |
Why?
|
| Cell Adhesion | 1 | 2020 | 420 | 0.170 |
Why?
|
| Lymph Nodes | 2 | 2023 | 533 | 0.160 |
Why?
|
| T-Lymphocytes | 2 | 2022 | 1195 | 0.160 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 1 | 2017 | 2 | 0.160 |
Why?
|
| Acetals | 1 | 2017 | 3 | 0.160 |
Why?
|
| Kinetics | 1 | 2021 | 1513 | 0.160 |
Why?
|
| Amphotericin B | 1 | 2017 | 34 | 0.160 |
Why?
|
| Delayed-Action Preparations | 1 | 2017 | 116 | 0.150 |
Why?
|
| Immunotherapy | 1 | 2023 | 629 | 0.150 |
Why?
|
| Adaptive Immunity | 2 | 2018 | 164 | 0.150 |
Why?
|
| Cytokines | 1 | 2021 | 778 | 0.150 |
Why?
|
| Dimerization | 1 | 2016 | 143 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2021 | 1961 | 0.140 |
Why?
|
| Combinatorial Chemistry Techniques | 2 | 2019 | 7 | 0.140 |
Why?
|
| Glucose | 1 | 2019 | 638 | 0.140 |
Why?
|
| Interleukin-6 | 1 | 2016 | 256 | 0.130 |
Why?
|
| Photochemical Processes | 1 | 2015 | 14 | 0.130 |
Why?
|
| Coculture Techniques | 1 | 2015 | 164 | 0.130 |
Why?
|
| Aminoquinolines | 1 | 2014 | 17 | 0.130 |
Why?
|
| Protein Structure, Quaternary | 1 | 2014 | 99 | 0.120 |
Why?
|
| Ultraviolet Rays | 1 | 2015 | 193 | 0.120 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2014 | 15 | 0.120 |
Why?
|
| Tin Compounds | 1 | 2013 | 2 | 0.120 |
Why?
|
| Volatilization | 1 | 2013 | 5 | 0.120 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2014 | 30 | 0.120 |
Why?
|
| Cell Movement | 1 | 2017 | 758 | 0.120 |
Why?
|
| Oxalates | 1 | 2013 | 48 | 0.120 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2013 | 45 | 0.110 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 253 | 0.110 |
Why?
|
| RNA | 1 | 2017 | 560 | 0.110 |
Why?
|
| Signal Transduction | 2 | 2014 | 3243 | 0.110 |
Why?
|
| Protein Multimerization | 1 | 2014 | 173 | 0.110 |
Why?
|
| Ethanolamine | 1 | 2012 | 2 | 0.110 |
Why?
|
| Adsorption | 1 | 2012 | 54 | 0.110 |
Why?
|
| Fibroblasts | 1 | 2015 | 729 | 0.100 |
Why?
|
| Surface Properties | 1 | 2011 | 130 | 0.100 |
Why?
|
| Particle Size | 1 | 2011 | 122 | 0.100 |
Why?
|
| Pyridoxal Phosphate | 1 | 2010 | 13 | 0.100 |
Why?
|
| Drug Design | 2 | 2023 | 124 | 0.100 |
Why?
|
| Phosphorylation | 1 | 2013 | 1106 | 0.100 |
Why?
|
| Immunity | 2 | 2023 | 136 | 0.100 |
Why?
|
| Immunogenicity, Vaccine | 2 | 2021 | 13 | 0.100 |
Why?
|
| Peptide Library | 1 | 2010 | 84 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 579 | 0.090 |
Why?
|
| Chemistry Techniques, Synthetic | 2 | 2019 | 9 | 0.080 |
Why?
|
| Inteins | 1 | 2008 | 3 | 0.080 |
Why?
|
| Mesna | 1 | 2008 | 9 | 0.080 |
Why?
|
| Chitin | 1 | 2008 | 10 | 0.080 |
Why?
|
| Models, Biological | 1 | 2015 | 1749 | 0.080 |
Why?
|
| Amines | 1 | 2008 | 27 | 0.080 |
Why?
|
| Acrylamides | 1 | 2008 | 30 | 0.080 |
Why?
|
| Chromatography, Affinity | 1 | 2008 | 81 | 0.080 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 2426 | 0.080 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 305 | 0.070 |
Why?
|
| Angiotensin I | 1 | 2006 | 6 | 0.070 |
Why?
|
| Aniline Compounds | 1 | 2006 | 55 | 0.070 |
Why?
|
| Polyethylene Glycols | 1 | 2008 | 363 | 0.070 |
Why?
|
| Protein Engineering | 1 | 2006 | 140 | 0.070 |
Why?
|
| Cross-Priming | 1 | 2023 | 48 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2021 | 2232 | 0.060 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 2022 | 5 | 0.050 |
Why?
|
| Hemagglutinins | 1 | 2022 | 19 | 0.050 |
Why?
|
| Phase Transition | 1 | 2021 | 17 | 0.050 |
Why?
|
| Wood | 1 | 2021 | 19 | 0.050 |
Why?
|
| Guinea Pigs | 1 | 2021 | 171 | 0.050 |
Why?
|
| Histocompatibility | 1 | 2021 | 71 | 0.050 |
Why?
|
| Antibodies, Viral | 1 | 2022 | 293 | 0.050 |
Why?
|
| Cellulose | 1 | 2021 | 55 | 0.050 |
Why?
|
| Antigens, Bacterial | 1 | 2021 | 134 | 0.050 |
Why?
|
| Immunoglobulin G | 1 | 2022 | 456 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2021 | 1014 | 0.040 |
Why?
|
| Transition Temperature | 1 | 2017 | 9 | 0.040 |
Why?
|
| Structure-Activity Relationship | 1 | 2019 | 408 | 0.040 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2017 | 23 | 0.040 |
Why?
|
| Lung | 1 | 2023 | 1170 | 0.040 |
Why?
|
| Antifungal Agents | 1 | 2017 | 117 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2015 | 81 | 0.030 |
Why?
|
| Bacterial Proteins | 1 | 2021 | 864 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 2062 | 0.030 |
Why?
|
| Catalysis | 1 | 2011 | 203 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2010 | 116 | 0.020 |
Why?
|
| Female | 3 | 2019 | 44537 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2010 | 279 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2010 | 210 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 881 | 0.020 |
Why?
|
| Cyclization | 1 | 2006 | 10 | 0.020 |
Why?
|
| Pyruvates | 1 | 2006 | 11 | 0.020 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 74 | 0.020 |
Why?
|
| Biomimetics | 1 | 2006 | 29 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2006 | 178 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2006 | 373 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 3030 | 0.020 |
Why?
|
| Male | 1 | 2015 | 40973 | 0.010 |
Why?
|